ALBANY, New York, 16 déc. 2023 (GLOBE NEWSWIRE) — Curia, un organisme de premier plan spcialis dans la recherche, le dveloppement et la fabrication sous contrat dans le secteur pharmaceutique, annonce aujourd'hui la [...] Read more »
Curia Nomeia Gerald Auer como Diretor Financeiro
ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — A Curia, uma organizao lder em contratos de pesquisa, desenvolvimento e fabricao, anunciou hoje a nomeao de Gerald Auer como Diretor Financeiro. Ele se juntar organizao em 1 de janeiro [...] Read more »
Curia ernennt Gerald Auer zum Chief Financial Officer
ALBANY, New York, Dec. 16, 2023 (GLOBE NEWSWIRE) — Curia, ein fhrendes Auftragsforschungs–, Entwicklungs– und Produktionsunternehmen, gab heute die Ernennung von Gerald Auer zum Chief Financial Officer bekannt. Er wird [...] Read more »
Curia Appoints Gerald Auer as Chief Financial Officer
ALBANY, N.Y., Dec. 15, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced that Gerald Auer has been appointed as chief financial officer. He will join [...] Read more »
Barbara Bufkin et Diane Fanelli rejoignent le conseil d’administration de Duck Creek Technologies
BOSTON, 11 déc. 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, le fournisseur de solutions intelligentes qui dessine les futurs contours du secteur de l'assurance gnrale et IARD (incendies, accidents et risques divers), [...] Read more »
Duck Creek Technologies Appoints Barbara Bufkin and Diane Fanelli to Board of Directors
BOSTON, Dec. 11, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, the intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, has announced the appointments of Barbara Bufkin and [...] Read more »
Duck Creek Technologies Nomeia Barbara Bufkin e Diane Fanelli para seu Conselho Diretor
BOSTON, Dec. 11, 2023 (GLOBE NEWSWIRE) — A Duck Creek Technologies, fornecedora de solues inteligentes que definem o futuro do seguro de propriedade e acidentes (P&C) e geral, tem o prazer de anunciar a nomeao de Barbara Bufkin e [...] Read more »
Duck Creek Technologies beruft Barbara Bufkin und Diane Fanelli in den Verwaltungsrat
BOSTON, Dec. 11, 2023 (GLOBE NEWSWIRE) — Duck Creek Technologies, der Anbieter intelligenter Lsungen, der die Zukunft der Schaden– und Unfallversicherung definiert, hat die Ernennung von Barbara Bufkin und Diane Fanelli in den [...] Read more »
Zenas BioPharma Fortalece a Liderança Executiva com a Nomeação de Jennifer Fox como Diretora de Negócios e Financeira, e de Tanya Fischer, MD, Ph.D. como Dirigente de P&D e Médica
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — A Zenas BioPharma, uma empresa biofarmacutica global comprometida em se tornar lder no desenvolvimento e comercializao de terapias voltadas para inflamaes e imunologia (I&I), [...] Read more »
Zenas BioPharma stärkt seine Führungsspitze mit der Ernennung von Jennifer Fox als Chief Business Officer und Chief Financial Officer sowie von Tanya Fischer, M.D., PhD. als Leiterin von Forschung und Entwicklung und als Chief Medical Officer
WALTHAM, Massachusetts, Dec. 04, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, ein weltweit ttiges Biopharmazieunternehmen, das sich der Aufgabe verschrieben hat, eine fhrende Position in der Entwicklung und Vermarktung von [...] Read more »
Zenas BioPharma renforce sa direction avec la nomination de Jennifer Fox en tant que Chief Business Officer et Chief Financial Officer et de Tanya Fischer, M.D., PhD., en tant que Head of R&D et Chief Medical Officer
WALTHAM, Massachusetts, 04 déc. 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, un laboratoire biopharmaceutique d'envergure mondiale dtermin devenir un leader dans le dveloppement et la commercialisation de traitements dans les [...] Read more »
Zenas BioPharma Strengthens Executive Leadership with Appointment of Jennifer Fox as Chief Business Officer and Chief Financial Officer and Tanya Fischer, M.D., PhD. as Head of R&D and Chief Medical Officer
WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) [...] Read more »
LeddarTech ernennt Chris Stewart zum Chief Financial Officer
QUEBEC CITY, Kanada, Nov. 15, 2023 (GLOBE NEWSWIRE) — Read more »
LeddarTech Nomeia Chris Stewart como Diretor Financeiro
QUEBEC CITY, Canadá, Nov. 15, 2023 (GLOBE NEWSWIRE) — A Read more »
LeddarTech nomme Chris Stewart au poste de chef de la direction financière
QUÉBEC, Canada, 15 nov. 2023 (GLOBE NEWSWIRE) — Read more »